Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1993 Apr;35(4):413–418. doi: 10.1111/j.1365-2125.1993.tb04159.x

Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity.

U K Walle 1, G R Pesola 1, T Walle 1
PMCID: PMC1381553  PMID: 8485021

Abstract

1. The oral bioavailability of the beta 2-adrenoceptor agonist salbutamol has been proposed to be stereoselective, presumably due to presystemic sulphate conjugation. In the present study we examined the stereochemistry of the sulphation reaction in vitro using human tissue preparations. 2. Sulphation of salbutamol was studied with partially purified hepatic M and P form phenol sulphotransferases (PSTs), 100,000 g cytosol of jejunal mucosa and platelet homogenate. The cosubstrate PAP35S was used as the sulphate donor. The acceptor substrate was either (+)-, (-)-or (+/)-salbutamol. 3. Sulphation was catalyzed by the M form PST of the liver but not the P form. The sulphation efficiency (Vmax/Km) was 11.9-fold greater for the (-)- than for the (+)- enantiomer, due entirely to a lower apparent Km for (-)-salbutamol, 103 microM, than for (+)-salbutamol, 1394 microM. 4. Sulphation by the jejunal mucosa (n = 3) was very similar to that of the M form PST with the efficiency being 9.8-fold greater for the (-)-enantiomer and apparent Km values 95 microM and 889 microM for (-)- and (+)-salbutamol, respectively. 5. Sulphation by the platelet (n = 3) was also very similar to that of the M form PST with the efficiency being 9.9-fold greater for the (-)-enantiomer and apparent Km values 141 microM and 1190 microM for (-)- and (+)-salbutamol, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
413

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R. J., Weinshilboum R. M. Phenolsulphotransferase in human tissue: radiochemical enzymatic assay and biochemical properties. Clin Chim Acta. 1980 Apr 11;103(1):79–90. doi: 10.1016/0009-8981(80)90233-8. [DOI] [PubMed] [Google Scholar]
  2. Anderson R. J., Weinshilboum R. M. Phenolsulphotransferase: enzyme activity and endogenous inhibitors in the human erythrocyte. J Lab Clin Med. 1979 Jul;94(1):158–171. [PubMed] [Google Scholar]
  3. Borgström L., Nyberg L., Jönsson S., Lindberg C., Paulson J. Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate. Br J Clin Pharmacol. 1989 Jan;27(1):49–56. doi: 10.1111/j.1365-2125.1989.tb05334.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Campbell N. R., Van Loon J. A., Weinshilboum R. M. Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form. Biochem Pharmacol. 1987 May 1;36(9):1435–1446. doi: 10.1016/0006-2952(87)90108-0. [DOI] [PubMed] [Google Scholar]
  5. Foldes A., Meek J. L. Rat brain phenolsulfotransferase: partial purification and some properties. Biochim Biophys Acta. 1973 Dec 19;327(2):365–374. doi: 10.1016/0005-2744(73)90419-1. [DOI] [PubMed] [Google Scholar]
  6. Heroux J. A., Falany C. N., Roth J. A. Immunological characterization of human phenol sulfotransferase. Mol Pharmacol. 1989 Jul;36(1):29–33. [PubMed] [Google Scholar]
  7. Heroux J. A., Roth J. A. Physical characterization of a monoamine-sulfating form of phenol sulfotransferase from human platelets. Mol Pharmacol. 1988 Aug;34(2):194–199. [PubMed] [Google Scholar]
  8. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  9. Lin C., Li Y., McGlotten J., Morton J. B., Symchowicz S. Isolation and identification of the major metabolite of albuterol in human urine. Drug Metab Dispos. 1977 May-Jun;5(3):234–238. [PubMed] [Google Scholar]
  10. Morgan D. J. Clinical pharmacokinetics of beta-agonists. Clin Pharmacokinet. 1990 Apr;18(4):270–294. doi: 10.2165/00003088-199018040-00002. [DOI] [PubMed] [Google Scholar]
  11. Morgan D. J., Paull J. D., Richmond B. H., Wilson-Evered E., Ziccone S. P. Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. Br J Clin Pharmacol. 1986 Nov;22(5):587–593. doi: 10.1111/j.1365-2125.1986.tb02939.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pesola G. R., Walle T. Enantiomeric interaction in the sulfate conjugation of the beta 2-agonist drug albuterol by the human liver. Res Commun Chem Pathol Pharmacol. 1992 Jan;75(1):125–128. [PubMed] [Google Scholar]
  13. Reiter C., Mwaluko G., Dunnette J., Van Loon J., Weinshilboum R. Thermolabile and thermostable human platelet phenol sulfotransferase. Substrate specificity and physical separation. Naunyn Schmiedebergs Arch Pharmacol. 1983 Sep;324(2):140–147. doi: 10.1007/BF00497020. [DOI] [PubMed] [Google Scholar]
  14. Shwed J. A., Walle U. K., Walle T. Hep G2 cell line as a human model for sulphate conjugation of drugs. Xenobiotica. 1992 Aug;22(8):973–982. doi: 10.3109/00498259209049903. [DOI] [PubMed] [Google Scholar]
  15. Sundaram R. S., Szumlanski C., Otterness D., van Loon J. A., Weinshilboum R. M. Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form. Drug Metab Dispos. 1989 May-Jun;17(3):255–264. [PubMed] [Google Scholar]
  16. Tan Y. K., Soldin S. J. Analysis of salbutamol enantiomers in human urine by chiral high-performance liquid chromatography and preliminary studies related to the stereoselective disposition kinetics in man. J Chromatogr. 1987 Nov 27;422:187–195. doi: 10.1016/0378-4347(87)80451-6. [DOI] [PubMed] [Google Scholar]
  17. Walle T., Walle U. K. Stereoselective sulfate conjugation of 4-hydroxypropranolol and terbutaline by the human liver phenolsulfotransferases. Drug Metab Dispos. 1992 Mar-Apr;20(2):333–336. [PubMed] [Google Scholar]
  18. Walle T., Walle U. K. Stereoselective sulfate conjugation of racemic 4-hydroxypropranolol by human and rat liver cytosol. Drug Metab Dispos. 1991 Mar-Apr;19(2):448–453. [PubMed] [Google Scholar]
  19. Walle T., Walle U. K. Stereoselective sulphate conjugation of racemic terbutaline by human liver cytosol. Br J Clin Pharmacol. 1990 Jul;30(1):127–133. doi: 10.1111/j.1365-2125.1990.tb03752.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Walle U. K., Walle T. Stereoselective sulfate conjugation of 4-hydroxypropranolol in humans: comparison of platelet and hepatic activity. Drug Metab Dispos. 1991 Jul-Aug;19(4):838–840. [PubMed] [Google Scholar]
  21. Weinshilboum R. M. Phenol sulfotransferase in humans: properties, regulation, and function. Fed Proc. 1986 Jul;45(8):2223–2228. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES